Cardiovascular disease kills more women than any other cause worldwide, yet much of what medicine has historically understood about heart disease comes from studies of middle-aged men. Women face a distinct constellation of risks that span their reproductive lives, from conditions like polycystic ovary syndrome in their twenties to the sharp rise in coronary events after menopause. Their heart attacks can look and feel different, their arteries fail in ways standard tests sometimes miss, and even the drugs used to treat them can behave differently in their bodies. Understanding these differences is not academic trivia; it changes how early warning signs are recognized, how quickly treatment happens, and ultimately who survives.
How Heart Disease Looks Different in Women’s Arteries
The classic image of a heart attack involves a large cholesterol plaque rupturing inside a major coronary artery and triggering a clot. That does happen to women, but it is not the whole story. A substantial share of women who develop chest pain or other signs of reduced blood flow to the heart have no significant blockages in their large coronary arteries. Up to half of these patients turn out to have coronary microvascular dysfunction, a condition in which the tiny blood vessels feeding the heart muscle cannot dilate properly or go into spasm.1Europe PMC / JAMA. Coronary Microvascular Dysfunction Causing Cardiac Ischemia in Women Because standard angiography is designed to spot blockages in large arteries, microvascular dysfunction can be invisible on routine testing, and women are sometimes told nothing is wrong when something clearly is.
When women do develop plaque problems, the pattern shifts with age. Younger women are more likely to experience plaque erosion, where the surface of a deposit wears away and exposes the blood to clot-forming material, while older women increasingly develop the classic plaque rupture pattern seen in men.2PubMed. Sex differences in coronary artery disease: pathological observations Imaging studies confirm this age-dependent trend: women show a rising frequency of vulnerable plaque features like thin fibrous caps and inflammatory cells as they age, a pattern not seen as clearly in men.3PubMed. Sex Differences in Culprit Plaque Characteristics Among Different Age Groups in Patients With Acute Coronary Syndromes The practical implication is that a 45-year-old woman having a heart attack may have a very different type of arterial injury than a 70-year-old woman, and both may differ from what clinicians are most trained to spot.
Why Symptoms Get Missed
Chest pain remains the most common symptom for both sexes during a heart attack. The idea that women never get chest pain is a myth. But the additional symptoms that come alongside chest pain tend to be more numerous and more varied in women, which can muddy the picture. A review of acute coronary syndrome presentations found that women reported an average of about 2.6 associated symptoms compared with roughly 1.8 in men, and those extra symptoms included things like upper back pain, jaw pain, nausea, shortness of breath, fatigue, and dizziness.4JAMA Internal Medicine. Symptom Presentation of Women With Acute Coronary Syndromes: Myth vs Reality In one hospital-based study, roughly 85% of women presented with atypical features like sweating, palpitations, fainting, or back pain, compared with about 70% of men.5PubMed Central. Atypical Manifestations of Women Presenting with Myocardial Infarction at Tertiary Health Care Center: An Analytical Study
The chest pain itself often has a different character. Women more frequently describe a squeezing or tightness sensation rather than the crushing pressure that dominates textbook descriptions. When these less-classic symptoms appear in a younger woman, they are easy to dismiss as anxiety or indigestion, both by the patient and by the emergency department. The diagnostic challenge is compounded by the fact that standard exercise treadmill testing has a lower positive predictive value in women, partly because microvascular dysfunction and nonobstructive disease can throw off test accuracy.6PubMed Central. Noninvasive Evaluation of Symptomatic Women with Suspected Coronary Artery Disease So even when a woman does seek care, the initial workup can come back looking reassuringly normal while the underlying problem persists.
Estrogen and the Menopause Inflection Point
Before menopause, women have a notably lower rate of cardiovascular disease than men of the same age. Much of this gap is attributed to estrogen, which promotes the production of nitric oxide in blood vessel walls, helps prevent the earliest stages of plaque formation, and supports the repair of damaged vessel linings.7PubMed. Estrogen receptors and endothelium After menopause, that protection fades. The incidence of cardiovascular disease in postmenopausal women climbs above that of age-matched men.8PubMed Central. Protective Effects of Estrogen on Cardiovascular Disease Mediated by Oxidative Stress
An American Heart Association scientific statement describes the menopause transition as a period of accelerating cardiovascular risk, noting unfavorable shifts in body composition, cholesterol levels, and blood vessel stiffness that cluster during this window.9PubMed. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association One study found that premenopausal women had roughly a third the odds of cardiovascular disease compared to postmenopausal women.10PubMed Central. Cardiovascular Disease Risk in Women with Menopause Early menopause, before age 47, further increases the risk. Data from the UK Biobank found that early menopause was associated with about a 33% higher hazard of cardiovascular events.11PubMed. Women’s reproductive factors and incident cardiovascular disease in the UK Biobank The message from this body of research is that midlife is a critical window, and risk factor monitoring during the menopausal transition can catch problems that would otherwise go unmanaged for years.
Polycystic Ovary Syndrome and Early Risk
Cardiovascular risk in women does not begin at menopause. Polycystic ovary syndrome, one of the most common hormonal conditions in women of reproductive age, brings a cluster of metabolic problems including insulin resistance, unfavorable cholesterol profiles, chronic low-grade inflammation, and higher blood pressure.12PubMed Central. Cardiovascular Risk in Women With PCOS Because PCOS typically begins in adolescence or early adulthood, these women accumulate cardiovascular damage over decades. A prospective cohort study found that women with PCOS had roughly two to three times the risk of major adverse cardiovascular events compared with controls, even after adjusting for body weight, and the hazard curves started diverging as early as age 35.13European Journal of Endocrinology. Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria—a prospective population-based cohort study PCOS is often thought of purely as a fertility issue, but its cardiovascular implications deserve equal attention.
Pregnancy as a Cardiovascular Stress Test
Pregnancy places enormous demands on the heart and blood vessels, and complications during pregnancy can signal long-term cardiovascular trouble. Preeclampsia is the most well-studied example. A meta-analysis found that women who experienced preeclampsia had roughly a fourfold higher risk of heart failure and about double the risk of coronary heart disease, stroke, and cardiovascular death compared with women whose pregnancies were uncomplicated.14PubMed. Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis A large population-based study and meta-analysis confirmed elevated hazard ratios for both ischemic heart disease and stroke in women with a preeclampsia history.15PubMed Central. Long-term cardiovascular outcome in women with preeclampsia in Korea: a large population-based cohort study and meta-analysis The prevailing view is that preeclampsia and cardiovascular disease share underlying mechanisms like endothelial dysfunction and inflammation, meaning pregnancy unmasks a vulnerability rather than creating one from scratch.16PubMed Central. Long-Term Cardiovascular Risk and Maternal History of Pre-Eclampsia
Gestational diabetes carries its own cardiovascular legacy. A systematic review and meta-analysis concluded that women diagnosed with gestational diabetes have about twice the risk of cardiovascular events after delivery compared with their peers, and this elevated risk appears within the first decade postpartum regardless of whether the woman later develops type 2 diabetes.17PubMed. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis Genetic research suggests that the link between gestational diabetes and later coronary artery disease may be partly mediated through the eventual development of high blood pressure and type 2 diabetes, highlighting modifiable targets for prevention.18PubMed. Gestational diabetes and future cardiovascular diseases: associations by sex-specific genetic data
Peripartum cardiomyopathy is a rarer but more acute threat: a form of heart failure that strikes around the time of delivery, sometimes without warning. Risk factors include older maternal age, hypertensive disorders of pregnancy, and carrying multiples.19PubMed. Peripartum Cardiomyopathy: JACC State-of-the-Art Review Part of the danger is that symptoms of heart failure, such as breathlessness, leg swelling, and fatigue, overlap heavily with the discomforts of normal late pregnancy, which can delay diagnosis. Outcomes range from full recovery to persistent heart failure and death, and a subsequent pregnancy carries a real risk of relapse if the heart has not fully recovered.20PubMed. Peripartum Cardiomyopathy
Conditions That Overwhelmingly Affect Women
Two cardiovascular conditions are so heavily female-predominant that they were barely recognized in the era when heart disease research focused on men. Spontaneous coronary artery dissection, or SCAD, occurs when a coronary artery wall tears spontaneously, forming a blood pocket that compresses the channel and starves the heart of blood. The female-to-male ratio is roughly 9 to 1, and SCAD is estimated to account for about 35% of acute coronary syndrome cases in women under 60.21PubMed Central. A review of the risk and precipitating factors for spontaneous coronary artery dissection Unlike typical heart attacks, SCAD tends to occur in people without the usual risk factors like high cholesterol or smoking. Instead, it is linked to fibromuscular dysplasia, connective tissue disorders, pregnancy, and emotional stress as a trigger.22PubMed Central. Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association The typical SCAD patient profile, a young, otherwise healthy woman, sits completely outside the pattern clinicians were trained to expect for a heart attack.
Takotsubo cardiomyopathy, sometimes called broken heart syndrome, is another condition that predominantly affects women. Over 80% to 90% of cases occur in postmenopausal women.23Europe PMC / Korean Circulation Journal. Stress-induced cardiomyopathy: a need for prospective multicenter trials Triggered by intense emotional or physical stress, it causes a sudden, temporary ballooning of the left ventricle that mimics a heart attack on initial testing but involves no blocked arteries. The condition usually reverses within weeks, but it is not benign: complications including cardiogenic shock and arrhythmias can be life-threatening during the acute phase.
Autoimmune Disease, Stress, and the Inflammation Connection
Autoimmune rheumatic diseases affect roughly 8% of the general population, and about 78% of those affected are women.24PubMed. Pathophysiology and imaging of heart failure in women with autoimmune rheumatic diseases Conditions like rheumatoid arthritis and lupus drive chronic systemic inflammation, which accelerates atherosclerosis. In a large prospective cohort of women, rheumatoid arthritis was associated with a significantly increased risk of heart attack.25PubMed. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis Standard cardiovascular risk calculators were not designed to account for this kind of inflammatory burden, so they tend to underestimate risk in women with autoimmune conditions.26PubMed Central. Cardiovascular Implications of Immune Disorders in Women
Psychosocial stress is another risk factor that hits women disproportionately hard. A review in the Journal of the American College of Cardiology described how stressors like socioeconomic disadvantage, childhood adversity, intimate partner violence, and caregiving responsibilities are especially common among women and may have more pronounced cardiovascular consequences in women than in men, in part because of sex differences in vascular reactivity and inflammatory responses to stress.27PubMed Central. The Role of Psychosocial Stress on Cardiovascular Disease in Women: JACC State-of-the-Art Review Depression, which affects roughly 20% to 25% of women over a lifetime, is increasingly considered a cardiovascular risk factor in its own right, linked to the disease through pathways that include nervous system overactivation and hormonal disruption.28PubMed. Depression and cardiovascular disease: The deep blue sea of women’s heart
Treatment Delays and the Clinical Trial Gap
Even when women arrive at a hospital with a clear heart attack, they tend to be treated more slowly. A systematic review of door-to-balloon times in ST-elevation heart attacks found that women consistently experienced longer delays before their blocked artery was opened compared with men.29PubMed. The Effect of Sex on Door-to-Balloon Time in Patients Presenting With ST-Elevation Myocardial Infarction and Referred for Primary Percutaneous Coronary Intervention: A Systematic Review One study found that women’s symptom-to-door and door-to-balloon times were about 29 and 8 minutes longer than men’s, respectively, and that female sex independently predicted higher 30-day mortality after an ST-elevation heart attack.30PubMed Central. Sex Differences Persist in Time to Presentation, Revascularization, and Mortality in Myocardial Infarction Treated With Percutaneous Coronary Intervention The delay begins before the hospital, with women taking longer to seek care, and continues inside it, with longer times from triage to diagnosis.31PubMed. Evaluation of gender differences in Door-to-Balloon time in ST-elevation myocardial infarction
Behind these treatment gaps is a broader knowledge gap. Women make up roughly half of heart failure patients, yet they have constituted only about 29% of participants in the heart failure trials that inform practice guidelines.32PubMed Central. Representation of women in heart failure clinical trials: Barriers to enrollment and strategies to close the gap Across all cardiovascular trial types between 2010 and 2017, women accounted for about 38% of participants, with especially low representation in acute coronary syndrome and arrhythmia trials.33PubMed. Women’s Participation in Cardiovascular Clinical Trials From 2010 to 2017 This means the evidence base that clinicians rely on was built mostly from men’s bodies, and the extent to which findings translate fully to women is often assumed rather than demonstrated.
When the Same Drug Works Differently
Sex-based differences in how the body processes drugs are real and clinically meaningful. Women tend to have different body composition, organ blood flow, enzyme activity, and kidney clearance rates, all of which can change how long a drug stays in the system and how strongly it acts. These are not small theoretical differences: hospital admissions for adverse reactions to cardiovascular drugs show clear sex-based patterns.34PubMed Central. Sex differences in cardiovascular drug-induced adverse reactions causing hospital admissions
One well-documented example involves drugs that prolong the heart’s electrical recovery period. Even after careful weight-based dosing and matching blood drug levels, roughly two-thirds of dangerous heart rhythm disturbances caused by QT-prolonging drugs occur in women. Women also have higher baseline platelet reactivity and a greater tendency toward what clinicians call aspirin resistance, meaning the standard dose of aspirin may be less effective at preventing clots in women than in men.35European Heart Journal – Cardiovascular Pharmacotherapy. Gender differences in the effects of cardiovascular drugs These differences are not obscure pharmacology footnotes; they affect whether the medications women are prescribed are working as intended and whether side effects are being anticipated.
Breast Cancer Treatment and the Heart
Because breast cancer overwhelmingly affects women, the cardiovascular side effects of its treatment represent a female-specific cardiac risk in practice. Anthracycline chemotherapy, a common first-line treatment, can cause dose-dependent and generally irreversible damage to the heart muscle. Trastuzumab, frequently combined with anthracyclines, adds its own risk of cardiac dysfunction, though this tends to be reversible when caught early.36PubMed Central. Cardiotoxicity in Breast Cancer Therapy: Risks, Mechanisms, and Prevention Strategies The field of cardio-oncology has grown specifically to manage this overlap, with cardiologists working alongside oncologists to monitor heart function during and after cancer treatment.37PubMed. Management of Cardiovascular Disease in Women With Breast Cancer For a breast cancer survivor, the risk of dying from heart disease can eventually rival or exceed the risk of the cancer recurring, making long-term cardiac follow-up after treatment genuinely important.
Reproductive History as a Risk Factor Map
Beyond the acute conditions of preeclampsia and gestational diabetes, a woman’s broader reproductive timeline carries cardiovascular information. UK Biobank data covering hundreds of thousands of women found that early first menstruation (before age 12) was associated with about a 10% higher risk of cardiovascular disease, and each miscarriage added a small but measurable increment of risk. Each stillbirth was associated with roughly a 14% higher hazard. Earlier age at first birth also increased risk slightly, as did each additional child.11PubMed. Women’s reproductive factors and incident cardiovascular disease in the UK Biobank No single one of these factors is dramatic on its own, but taken together, they paint a picture: the reproductive system and the cardiovascular system are deeply intertwined, and the cumulative history matters. A detailed pregnancy and menstrual history is not a gynecological curiosity during a cardiac evaluation; it is a meaningful part of the risk assessment that clinicians are only recently learning to use systematically.